Byram Ozer

Assistant Professor

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Byram Ozer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Glioblastoma Medicine & Life Sciences
Methylation Medicine & Life Sciences
Biological Specimen Banks Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Survival Medicine & Life Sciences
O(6)-Methylguanine-DNA Methyltransferase Medicine & Life Sciences
Body Fluid Compartments Medicine & Life Sciences
Isocitrate Dehydrogenase Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden

Nguyen, H. T., Nguyen, N., Liu, L. Y., Dovek, L., Lenchner, D., Harris, R., Ozer, B., Ravelo, A., Sommer, N., Sim, M. S., Elashoff, R., Green, R., Nghiemphu, P. L., Cloughesy, T. F., Ellingson, B. & Lai, A., Mar 29 2019, In : Neuro-Oncology Practice. 6, 2, p. 103-111 9 p.

Research output: Contribution to journalArticle

Tumor Burden

Correlation of commercially available quantitative MGMT (O-6-methylguanine-DNA methyltransferase) promoter methylation scores and GBM patient survival

Dovek, L., Nguyen, N. T., Ozer, B., Li, N., Elashoff, R. M., Green, R. M., Liau, L., Leia Nghiemphu, P., Cloughesy, T. F. & Lai, A., Jun 1 2019, In : Neuro-Oncology Practice. 6, 3, p. 194-202 9 p.

Research output: Contribution to journalReview article

O(6)-Methylguanine-DNA Methyltransferase
Los Angeles

SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation

Liu, F., Cox, C. D., Chowdhury, R., Dovek, L., Nguyen, H., Li, T., Li, S., Ozer, B., Chou, A., Nguyen, N., Wei, B., Antonios, J., Soto, H., Kornblum, H., Liau, L., Prins, R., Nghiemphu, P. L., Yong, W., Cloughesy, T. & Lai, A., Jan 1 2019, In : Journal of neuro-oncology.

Research output: Contribution to journalArticle

CpG Islands

D-2-hydroxyglutarate Is necessary and sufficient for isocitrate dehydrogenase 1 mutant-induced MIR148A promoter methylation

Li, T., Cox, C. D., Ozer, B., Nguyen, N. T., Nguyen, H. N., Lai, T. J., Li, S., Liu, F., Kornblum, H. I., Liau, L. M., Nghiemphu, P. L., Cloughesy, T. F. & Lai, A., Jun 1 2018, In : Molecular Cancer Research. 16, 6, p. 947-960 14 p.

Research output: Contribution to journalArticle

Isocitrate Dehydrogenase
CpG Islands
HEK293 Cells

Emerging Agency or Arrested Development? Proceed With Caution

Raho, J. A. & Ozer, B., Jan 2 2018, In : AJOB Neuroscience. 9, 1, p. 65-66 2 p.

Research output: Contribution to journalComment/debate